testosterone cypionate 200 mg/mL Injection, Solution, 1 vial
by Ajenat Pharmaceuticals LLC · 1 VIAL, SINGLE-DOSE in 1 CARTON (82983-425-01) / 1 mL in 1 VIAL, SINGLE-DOSE
NDC 82983-0425-01
🏷️ FDA NDC (as labeled)
82983-425-01
billing pads the product segment with a zero
Rx only
Generic
On market
CIII
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Testosterone Cypionate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 10, 2025 — cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. (Eugia US LLC) · FDA recall D-0363-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
🆔 Identity & classification
FDA NDC (as labeled)
82983-425-01
Product NDC
82983-425
11-digit billing NDC
82983042501
Application #
ANDA219478
SPL Set ID
cd57648c-ce53-459a-9f14-3984fc464428
Established class (EPC)
Androgen
Mechanism of action
Androgen Receptor Agonists
Chemical class
Androstanes
DEA schedule
CIII
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2026-09-14
Route
INTRAMUSCULAR
Dosage form
INJECTION, SOLUTION
Substance
TESTOSTERONE CYPIONATE
Why two NDCs?
The FDA registers this code as 82983-425-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82983-0425-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerAjenat Pharmaceuticals LLC
FDA applicationANDA219478 (ANDA)
Labeler code82983
First marketedSep 2026
DEA scheduleCIII
Product typeHuman Prescription Drug
Portfolio15 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- Testosterone replacement is specifically for men whose bodies aren't making enough testosterone because of a medical condition — like a problem with the testes themselves (primary...
- What exactly is testosterone replacement therapy for — do I really need it?
- Yes, this is a serious concern. Children who accidentally touch the gel on your skin or clothing can absorb testosterone and develop early puberty signs — things like pubic hair gr...
- I use the gel — do I really need to worry about my kids or partner being exposed to it?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about testosterone cypionate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
9.45 mg / 1 mL
UNII LKG8494WBH
Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
-
0.2 mL / 1 mL
UNII N863NB338G
Benzyl benzoate is a liquid organic compound used as a solvent and preservative in medicines. It helps dissolve active ingredients and can extend shelf life by preventing microbial growth in liquid formulations.
-
560 mg / 1 mL
UNII H3E878020N
Cottonseed oil is a natural vegetable oil extracted from cotton plant seeds. It is used in medicines as a solvent and lubricant to help dissolve active ingredients and allow smooth tablet or capsule movement through manufacturing equipment.
3 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| testosterone cypionate 200 mg/mL 47781-0910-91 | Alvogen | 10 vials | $2.235 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 62756-0016-40 | Sun | 1 vial | $3.286 | — | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 00143-9726-01 | Hikma | 10 ml | $3.651 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 00143-9005-01 | Hikma | 1 vial | $3.651 | AO | Availability likely | — |
| testosterone cypionate 200 mg/mL 70700-0290-22 | Xiromed | 1 vial | $3.651 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 62756-0015-40 | Sun | 1 vial | $11.349 | — | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 00574-0827-01 | Padagis | 1 vial | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 00143-9659-01 | Hikma | 1 ml | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 69097-0802-32 | Cipla | 1 vial | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 00409-6562-01 | Hospira, | 1 vial | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 55150-0277-01 | Eugia | 1 vial | $11.546 | AO | Availability likely | — |
| testosterone cypionate 200 mg/mL 72603-0286-01 | NorthStar | 1 vial | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 69097-0537-31 | Cipla | 1 ml | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 00574-0820-01 | Padagis | 1 vial | $11.546 | AO | Availability likely | — |
| testosterone cypionate 200 mg/mL 47781-0911-93 | Alvogen | 1 vial | $11.546 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 52536-0625-01 | Wilshire | 1 vial | $11.546 | AO | Availability likely | — |
| testosterone cypionate 200 mg/mL 70700-0289-22 | Xiromed | 1 vial | $11.546 | AO | Availability likely | — |
| Depo-Testosterone 200 mg/mL 00009-0086-01 | Pharmacia | 1 vial | $14.140 | AO | Availability likely | — |
| Depo-Testosterone 200 mg/mL 00009-0417-01 | Pharmacia | 1 vial | $14.140 | AO | Availability likely | — |
| Testosterone Cypionate 200 mg/mL 00517-1830-01 | American | 1 vial | $14.181 | AO | Discontinued | — |
| Testosterone Cypionate 200 mg/mL 63187-0647-10 | Proficient | 10 ml | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 71205-0289-01 | Proficient | 1 ml | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 76420-0065-10 | Asclemed | 10 ml | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 63629-8706-01 | Bryant | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 76420-0645-10 | Asclemed | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 76420-0741-10 | Asclemed | 1 vial | — | AO | FDA listed | — |
| testosterone cypionate 200 mg/mL 76420-0747-01 | Asclemed | 1 vial | — | AO | FDA listed | — |
| Azmiro 200 mg/mL 24338-0055-01 | Azurity | 1 syringe | — | — | FDA listed | — |
| Azmiro 200 mg/mL 24338-0056-01 | Azurity | 1 vial | — | — | FDA listed | — |
| testosterone cypionate 200 mg/mL 68071-3840-01 | NuCare | 10 vials | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 50090-4147-00 | A-S | 1 vial | — | AO | FDA listed | — |
| testosterone cypionate 200 mg/mL 50090-7585-00 | A-S | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 50090-7435-00 | A-S | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 71335-2470-01 | Bryant | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 72162-2348-02 | Bryant | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 68071-3809-01 | NuCare | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 72162-1119-02 | Bryant | 1 vial | — | AO | FDA listed | — |
| testosterone cypionate 200 mg/mL 68071-3835-01 | NuCare | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 50090-4920-00 | A-S | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 63629-8705-01 | Bryant | 1 vial | — | AO | FDA listed | — |
| testosterone cypionate 200 mg/mL 76420-0752-10 | Asclemed | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 70518-4538-00 | REMEDYREPACK | 1 ml | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 71335-2473-01 | Bryant | 1 vial | — | AO | FDA listed | — |
| testosterone cypionate 200 mg/mL 50090-7584-00 | A-S | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 76420-0746-01 | Asclemed | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 71335-2838-01 | Bryant | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 72162-2375-02 | Bryant | 1 vial | — | AO | FDA listed | — |
| Testosterone Cypionate 200 mg/mL 87063-0272-10 | ASCLEMED | 1 vial | — | AO | FDA listed | — |
| testosterone cypionate 200 mg/mLthis 82983-0425-01 | Ajenat | 1 vial | — | — | FDA listed | — |
| testosterone cypionate 200 mg/mL 82983-0424-01 | Ajenat | 1 vial | — | — | FDA listed | — |
| testosterone cypionate 200 mg/mL 54288-0150-01 | BPI | 1 vial | — | — | FDA listed | — |
| testosterone cypionate 200 mg/mL 54288-0156-01 | BPI | 1 vial | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2026
On the market since
Sep 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Testosterone Cypionate — the program that covers self-administered drugs. 12 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Testosterone Cypionate. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.24M
Claims incl. refills
320.7K
Beneficiaries
209.5K
Spend / beneficiary
$53.62
Spend / claim
$35.03
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Testosterone cypionate — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 93%
Female · 6%
Unknown · 1%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 82983-0425-01 You're viewing this | 1 VIAL, SINGLE-DOSE in 1 CARTON (82983-425-01) / 1 mL in 1 VIAL, SINGLE-DOSE | 2026-09-14 | Active |
🧭 About this NDC listing & data coverage
Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 82983-425-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 82983-0425-01, written without dashes as 82983042501. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 82983-0425-01, the first segment (82983) is the labeler code FDA assigned to Ajenat Pharmaceuticals LLC; the middle segment (0425) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Ajenat Pharmaceuticals LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Ajenat Pharmaceuticals LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.